Investopedia: Healthcare Outlook For The Week Ahead

With the Fourth of July holiday coming smack in the middle of the week, this week is likely to be light on news and investable events for investors. Trading volumes will likely be thin, and there are no scheduled announcements of any significance.

Will Glaxo up Its Bid? 
GlaxoSmithKline (NYSE:GSK) ended last week by extending its tender offer to acquire Human Genome Sciences (Nasdaq:HGSI), but has not increased its bid beyond the original $13 per share. With Human Genome shares trading just above $13, it seems that investors have only modest confidence that a higher bid will come, though RBC's Michael Yee recently published a note suggesting that a higher bid (of $15 per share) could be on the way.

Continue reading here:
http://stocks.investopedia.com/stock-analysis/2012/Healthcare-Outlook-For-The-Week-Ahead-HGSI-GSK-HCA-TEVA0703.aspx